{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:50:16Z","timestamp":1781067016023,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA042702"],"award-info":[{"award-number":["R21 DA042702"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA029910"],"award-info":[{"award-number":["R01 DA029910"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["FIC TW09338"],"award-info":[{"award-number":["FIC TW09338"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To reduce opioid dependence and HIV transmission, Kyrgyzstan has introduced methadone maintenance therapy and needle\/syringe programs into prisons. Illicit injection of diphenhydramine, an antihistamine branded as Dimedrol<jats:sup>\u00ae<\/jats:sup>, has been anecdotally reported as a potential challenge to harm reduction efforts in prisons but has not been studied systematically.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted qualitative interviews in Kyrgyz or Russian with prisoners (<jats:italic>n<\/jats:italic>\u2009=\u200949), former prisoners (<jats:italic>n<\/jats:italic>\u2009=\u200919), and stakeholders (<jats:italic>n<\/jats:italic>\u2009=\u200918), including prison administrators and prisoner advocates near Bishkek, Kyrgyzstan from October 2016 to September 2018. Interviews explored social\u2013contextual factors influencing methadone utilization in prisons. Transcripts were coded by five researchers using content analysis. Dimedrol injection emerged as an important topic, prompting a dedicated analysis.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After drinking methadone, some people in prison inject crushed Dimedrol tablets, a non-prescription antihistamine that is banned but obtainable in prison, to achieve a state of euphoria. From the perspectives of the study participants, Dimedrol injection was associated with devastating physical and mental health consequences, including psychosis and skin infections. Moreover, the visible wounds of Dimedrol injecting contributed to the perception of methadone as a harmful drug and supporting preference for heroin over methadone.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Dimedrol injecting is a potentially serious threat to harm reduction and HIV prevention efforts in Kyrgyzstan and elsewhere in the Eastern European and Central Asian region and requires further investigation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-020-00435-7","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T10:02:43Z","timestamp":1604138563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5735-385X","authenticated-orcid":false,"given":"Jaimie P.","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel J.","family":"Culbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyuba","family":"Azbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chethan","family":"Bachireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainura","family":"Kurmanalieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,31]]},"reference":[{"key":"435_CR1","unstructured":"UNAIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. UNAIDS; 2014."},{"key":"435_CR2","unstructured":"Avert. HIV and AIDS in Eastern Europe and Central Asia Overview 2019 (cited 2019 July 1). \n                  https:\/\/www.avert.org\/hiv-and-aids-eastern-europe-central-asia-overview\n                  \n                ."},{"key":"435_CR3","unstructured":"Joint United Nations Programme on HIV\/AIDS. Kyrgyzstan Country Factsheet: UNAIDS; 2019 (September 6, 2020). \n                  https:\/\/www.unaids.org\/en\/regionscountries\/countries\/kyrgyzstan\n                  \n                ."},{"key":"435_CR4","unstructured":"Walmsley R. World prison brief data: Kygyzstan: Institute for Criminal Policy Research; 2019 (09\/08\/20). \n                  https:\/\/www.prisonstudies.org\/country\/indonesia\n                  \n                ."},{"key":"435_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.drugpo.2016.06.007","volume":"37","author":"L Azbel","year":"2016","unstructured":"Azbel L, Polonsky M, Wegman M, Shumskaya N, Kurmanalieva A, Asanov A, et al. Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: implications for prevention and treatment. Int J Drug Policy. 2016;37:9\u201320.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"435_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1108\/IJPH-03-2017-0016","volume":"14","author":"L Azbel","year":"2018","unstructured":"Azbel L, Wegman MP, Polonsky M, Bachireddy C, Meyer J, Shumskaya N, et al. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments. Int J Prison Health. 2018;14(3):175\u201387.","journal-title":"Int J Prison Health"},{"key":"435_CR7","unstructured":"United Nations Office on Drugs and Crime (UNODC). A coordinated approach to tackling the drug situation in Kyrgyz prisons. UNODC Central Asia News; 2013."},{"key":"435_CR8","unstructured":"United Nations Office on Drugs and Crime. Policy brief: HIV prevention, treatment and care in prisons and other closed settings: a comprehensive package of interventions; 2013. \n                  https:\/\/www.unodc.org\/documents\/hiv-aids\/HIV_comprehensive_package_prison_2013_eBook.pdf\n                  \n                ."},{"key":"435_CR9","unstructured":"World Health Organization Regional Office for Europe. Evaluation of opioid substitution therapy in Kyrgyzstan; 2016."},{"key":"435_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.drugalcdep.2017.07.002","volume":"179","author":"A Deryabina","year":"2017","unstructured":"Deryabina A, El-Sadr WM. Uptake of needle and syringe program services in the Kyrgyz Republic: key barriers and facilitators. Drug Alcohol Depend. 2017;179:180\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"435_CR11","volume-title":"Rapid assessment in prisons","author":"A Zelichenko","year":"2006","unstructured":"Zelichenko A. Rapid assessment in prisons. Bishkek: CARHAP (The Central Asian HIV\/AIDS Programme); 2006."},{"key":"435_CR12","unstructured":"ICAP CU. Assessment of the medication assisted therapy program in the Kyrgyz Republic; 2012."},{"key":"435_CR13","unstructured":"FDA. Package Insert: Diphenhydramine Hydrochloride Injection, USP."},{"issue":"2","key":"435_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/1389200033489523","volume":"4","author":"A Sharma","year":"2003","unstructured":"Sharma A, Hamelin BA. Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a bird\u2019s eye view. Curr Drug Metab. 2003;4(2):105\u201329.","journal-title":"Curr Drug Metab"},{"issue":"4","key":"435_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.pbb.2008.09.013","volume":"91","author":"Z Wang","year":"2009","unstructured":"Wang Z, Woolverton WL. Super-additive interaction of the reinforcing effects of cocaine and H1-antihistamines in rhesus monkeys. Pharmacol Biochem Behav. 2009;91(4):590\u20135.","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"435_CR16","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3109\/10826088009040100","volume":"15","author":"C Wadley","year":"1980","unstructured":"Wadley C, Stillie GD. Pentazocine (Talwin) and tripelennamine (Pyribenzamine): a new drug abuse combination or just a revival? Int J Addict. 1980;15(8):1285\u201390.","journal-title":"Int J Addict"},{"issue":"2","key":"435_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/ADM.0b013e31827f9b43","volume":"7","author":"BJ Shapiro","year":"2013","unstructured":"Shapiro BJ, Lynch KL, Toochinda T, Lutnick A, Cheng HY, Kral AH. Promethazine misuse among methadone maintenance patients and community-based injection drug users. J Addict Med. 2013;7(2):96\u2013101.","journal-title":"J Addict Med"},{"key":"435_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.drugalcdep.2015.02.023","volume":"150","author":"KL Lynch","year":"2015","unstructured":"Lynch KL, Shapiro BJ, Coffa D, Novak SP, Kral AH. Promethazine use among chronic pain patients. Drug Alcohol Depend. 2015;150:92\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"435_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13011-016-0065-2","volume":"11","author":"D Otiashvili","year":"2016","unstructured":"Otiashvili D, Latypov A, Kirtadze I, Ibragimov U, Zule W. Drug preparation, injection, and sharing practices in Tajikistan: a qualitative study in Kulob and Khorog. Subst Abuse Treat Prev Policy. 2016;11(1):21.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"435_CR20","unstructured":"Teplinskaya I. A life in free fall: a Russian drug addict's story 2010 (updated 17 November 2010). \n                  https:\/\/www.opendemocracy.net\/od-russia\/irina-teplinskaya\/life-in-free-fall-russian-drug-addicts-story-2\n                  \n                ."},{"issue":"1","key":"435_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3109\/14659891.2012.661021","volume":"18","author":"M Turaeva","year":"2013","unstructured":"Turaeva M, Engmann B. A new pattern of drug abuse among injecting drug users in Tashkent city. J Subst Use. 2013;18(1):12\u201320.","journal-title":"J Subst Use"},{"key":"435_CR22","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/1467-9566.12978","volume":"41","author":"T Rhodes","year":"2019","unstructured":"Rhodes T, Azbel L, Lancaster K, Meyer J. The becoming-methadone-body. On the onto-politics of health intervention translations. Sociol Health Illness. 2019;41:1618\u201336.","journal-title":"Sociol Health Illness"},{"key":"435_CR23","first-page":"136248062093067","volume":"2019","author":"L Azbel","year":"2019","unstructured":"Azbel L, Morse E, Rhodes T. The collective body: legacies of monastic discipline in the post-Soviet prison. Theor Criminol. 2019;2019:1362480620930677.","journal-title":"Theor Criminol"},{"key":"435_CR24","unstructured":"Rozanova J, Azbel L, Kurmanalieva A, Shumskaya N, Marcus R, Lamonaca K, et al. HIV risk perceptions and risk reduction strategies among prisoners in Kyrgyzstan: a qualitative study. In: 22nd international AIDS conference. Amsterdam; 2018."},{"key":"435_CR25","unstructured":"Bachireddy C, Kurmanalieva A, Azbel L, Shumskaya N, Rozanova J, Meyer J, et al. Methadone maintenance therapy uptake, retention, and linkage for people who inject drugs transitioning from prison to the community in Kyrgyzstan: evaluation of a national program. In: 22nd international AIDS conference. Amsterdam; 2018."},{"key":"435_CR26","unstructured":"Marcus R, Azbel L, Culbert GJ, Rozanova J, Kurmanalieva A, Shumskaya N, et al. Uniquely successful implementation of methadone treatment in a women\u2019s prison in Kyrgyzstan. In: 11th International women\u2019s and children\u2019s health and gender (InWomen\u2019s) Group. San Antonio; 2019."},{"issue":"2","key":"435_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","volume":"13","author":"T Rhodes","year":"2002","unstructured":"Rhodes T. The \u2018risk environment\u2019: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85\u201394.","journal-title":"Int J Drug Policy"},{"key":"435_CR28","first-page":"1","volume":"2018","author":"L Azbel","year":"2018","unstructured":"Azbel L, Wegman M, Polonsky M, Bachireddy C, Meyer J, Sumskaya N, et al. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments. Int J Prison Health. 2018;2018:1\u201320.","journal-title":"Int J Prison Health"},{"key":"435_CR29","unstructured":"Substance Abuse and Mental Health Services Administration. TIP 63, Chapter 3B: Medications for Opioid Use Disorder: For Healthcare and Addiction Professionals, Policymakers, Patients, and Families. Treatment Improvement Protocol (TIP) Series, No. 63. Rockville (MD); 2018."},{"issue":"1","key":"435_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12888-017-1415-y","volume":"17","author":"PK Heikman","year":"2017","unstructured":"Heikman PK, Muhonen LH, Ojanper\u00e4 IA. Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine. BMC Psychiatry. 2017;17(1):245.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"435_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3109\/09687637.2016.1153604","volume":"23","author":"T Kolind","year":"2016","unstructured":"Kolind T, Duke K. Drugs in prisons: exploring use, control, treatment and policy. Drugs Educ Prevent Policy. 2016;23(2):89\u201392.","journal-title":"Drugs Educ Prevent Policy."},{"issue":"5","key":"435_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/10673229709030550","volume":"4","author":"EJ Khantzian","year":"1997","unstructured":"Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4(5):231\u201344.","journal-title":"Harv Rev Psychiatry"},{"key":"435_CR33","volume-title":"Social research method","author":"A Bryman","year":"2001","unstructured":"Bryman A. Social research method. Oxford: Oxford University Press; 2001."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-020-00435-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12954-020-00435-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-020-00435-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T01:09:13Z","timestamp":1604192953000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-020-00435-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,31]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["435"],"URL":"https:\/\/doi.org\/10.1186\/s12954-020-00435-7","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,31]]},"assertion":[{"value":"11 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants provided written informed consent in Kyrgyz or Russian. Ethics approval was obtained from Yale University Human Investigations Committee (IRB), including a prisoner representative, and from the Department of Health and Human Services, Office for Human Research Protections (OHRP). Ethics approval also was obtained from the Committee on Bioethics under the Global Research Institute in Kyrgyz Republic and the University of Illinois Chicago.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}